0

Journal Articles

in Diabetes Mellitus Type 2
 81-100 of 265 Articles
JAMA Patient Page |  FREE
Lise M. Stevens, MA; Cassio Lynm, MA; Richard M. Glass, MD
JAMA. 2009;301(6):686. doi:10.1001/jama.301.6.686.
INCLUDES: , Supplemental Content

Commentary | 
David Aron, MD, MS; Leonard Pogach, MD, MBA
JAMA. 2009;301(2):210-212. doi:10.1001/jama.2008.930.

Review |  FREE
JAMA. 2008;300(24):2886-2897. doi:10.1001/jama.2008.886.

From the Centers for Disease Control and Prevention |  FREE
JAMA. 2008;300(24):2847-2849. doi:10.1001/jama.300.24.2847.

Review |  FREE
Bethany B. Barone, ScM; Hsin-Chieh Yeh, PhD; Claire F. Snyder, PhD; et al.
JAMA. 2008;300(23):2754-2764. doi:10.1001/jama.2008.824.
INCLUDES: , Supplemental Content

Lab Reports | 
Carolyn J. Hildreth, MD
JAMA. 2008;300(21):2476. doi:10.1001/jama.2008.737.

Medical News & Perspectives | 
Tracy Hampton, PhD
JAMA. 2008;300(21):2471-2473. doi:10.1001/jama.2008.721.

Original Contribution |  FREE
Alessandro Doria, MD, PhD, MPH; Joanna Wojcik, MD; Rui Xu, MD, PhD; et al.
JAMA. 2008;300(20):2389-2397. doi:10.1001/jama.2008.649.

Editorial | 
Antonio Nicolucci, MD
JAMA. 2008;300(18):2180-2181. doi:10.1001/jama.2008.625.

Original Contribution |  FREE
Hisao Ogawa, MD, PhD; Masafumi Nakayama, MD, PhD; Takeshi Morimoto, MD, PhD; et al.
JAMA. 2008;300(18):2134-2141. doi:10.1001/jama.2008.623.

Commentary | 
Mark O. Goodarzi, MD, PhD; Bruce M. Psaty, MD, PhD
JAMA. 2008;300(17):2051-2053. doi:10.1001/jama.2008.510.

Lab Reports | 
Tracy Hampton, PhD
JAMA. 2008;300(17):1989. doi:10.1001/jama.2008.530.

Lab Reports | 
Tracy Hampton, PhD
JAMA. 2008;300(13):1508. doi:10.1001/jama.300.13.1508-d.

Original Contribution |  FREE
Iain A. Lang, PhD; Tamara S. Galloway, PhD; Alan Scarlett, PhD; et al.
JAMA. 2008;300(11):1303-1310. doi:10.1001/jama.300.11.1303.

Preliminary Communication |  FREE
Ana Navas-Acien, MD, PhD; Ellen K. Silbergeld, PhD; Roberto Pastor-Barriuso, PhD; et al.
JAMA. 2008;300(7):814-822. doi:10.1001/jama.300.7.814.

Health Agencies Update | 
JAMA. 2008;300(4):386. doi:10.1001/jama.2008.90.

Original Contribution |  FREE
Joachim H. Ix, MD, MAS; Christina L. Wassel, MS; Alka M. Kanaya, MD; et al.
JAMA. 2008;300(2):182-188. doi:10.1001/jama.300.2.182.

Original Contribution |  FREE
Sherita Hill Golden, MD, MHS; Mariana Lazo, MD, MSc; Mercedes Carnethon, PhD; et al.
JAMA. 2008;299(23):2751-2759. doi:10.1001/jama.299.23.2751.

Clinical Crossroads | 
Donald R. Coustan, MD
JAMA. 2008;299(21):2550-2557. doi:10.1001/jama.299.17.jrr80003.
INCLUDES: CME

Medical News & Perspectives | 
Tracy Hampton, PhD
JAMA. 2008;299(14):1654. doi:10.1001/jama.299.14.1654.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Correction  | 
Error in Table in: Communication and Medication Refill Adherence: The Diabetes Study of Northern California

JAMA Internal Medicine
Viewpoint  | 
Nullius In Verba:  Don't Take Anyone's Word for It
Richard S. Lehman, MA, BM,  BCh, MRCGP
JAMA Internal Medicine
Original Investigation  | 
Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus:  A Population-Based Matched Case-Control Study
Sonal Singh, MD, MPH; Hsien-Yen Chang, PhD; Thomas M. Richards, MS; et al.
JAMA Internal Medicine
Invited Commentary  | 
Glucagonlike Peptide 1–Based Drugs and Pancreatitis:  Clarity at Last, but What About Pancreatic Cancer?
Comment on “Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus”
Belinda Gier, PhD; Peter C. Butler, MD